Pages
- Home
- Prevention
- Colorectal Cancer
- What We Do
- Stories
- Support
- Get Involved
- Resources
- Blog
- Contact Us
- Advocate/Legacy
- New To CCC
- Touched By The Disease
- Sitemap
- Staff/Board/Medical Advisory
Posts by category
- Category: Blog
- Predicting recurrence in CRC using post-operative circulating tumour DNA
- Exercise linked to lower mortality risk across different cancer types
- Coping with Metastatic Cancer
- The FDA approves Lonsurf plus bevacizumab for metastatic colorectal cancer
- Liver transplant improves survival for certain patients with colorectal cancer liver metastases
- What does Research Say? The Impact of Meditation on Cancer-Treatment Side Effects.
- Fruquintinib significantly extends survival in refractory metastatic colorectal cancer
- Chemotherapy sequence in advanced colorectal cancer
- Patient-reported outcomes from the PROSPECT trial: treatment for locally advanced rectal cancer
- Trastuzumab deruxtecan shows activity in HER2+ metastatic colorectal cancer
- Stress Management: What stress does to your body and how to reduce it.
- Combination of patient, provider outreach boosts CRC screening in high-risk individuals
- A dedicated patient navigator improved FIT return rates by nearly 38%
- Preparing for an upcoming appointment
- Greater levels of inflammation after surgery and prior to chemotherapy associated to poorer survival in stage III colon cancer
- Financial toxicity of cancer may impact partner’s quality of life
- Novel immunotherapy combination showed high efficacy among patients with microsatellite stable metastatic colorectal cancer
- The psychological impact of surviving colorectal cancer
- Levels of cell-free DNA do not impact ctDNA detection in patients with CRC
- Trifluridine plus tipiracil and bevacizumab is a new standard of care for refractory metastatic colorectal cancer
- The CheckMate 8HW study: A study of nivolumab, nivolumab plus ipilimumab, or investigator’s choice chemotherapy for the treatment of participants with deficient mismatch repair (dMMR) / microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC)
- Exercise during chemo may help beat the treatment’s debilitating effects
- Differences in the gut microbiome by physical activity and BMI among colorectal cancer patients
- Diverticular disease associated with increased risk of multiple cancers
- Recent study provokes controversy about the effectiveness of colonoscopy as a screening test
- EXCEL: Technology and Exercise Adherence
- The FRESCO-2 trial: exploring treatment options for patients with metastatic colorectal cancer
- Effect of physical activity on disease-free survival in patients receiving adjuvant therapy
- Understanding ulcerative colitis: a risk factor for colorectal cancer
- Understanding Crohn’s disease: a risk factor for colorectal cancer
- Q&A with Dr. Brandon Sheffield, Pathologist
- Q&A with Suzanne Zwicker, clinical pharmacist
- ESMO World Congress on Gastrointestinal Cancer 2022
- Regional Therapy for Colorectal Cancer Liver Metastases
- Minimal Residual Disease (MRD) and CRC
- ASCO 2022
- HER2 Therapies for Patients with mCRC
- Overall survival associated with Pembrolizumab (Keytruda) vs. Chemotherapy in MSI-H/dMMR mCRC
- Alcohol intake and risk of alcohol-related cancer
- Associations between unprocessed red meat and processed meat with risk of recurrence and mortality in patients with stage III colon cancer
- Can weight loss in adulthood reduce the risk of developing colorectal adenomas?
- The emotional impact of a colorectal cancer diagnosis
- ASCO GI 2022: Trial evaluating immunotherapy in neoadjuvant setting for the treatment of locally advanced rectal cancer
- ASCO GI 2022: Key considerations about oxaliplatin for the treatment of mCRC
- Webinar: Supporting individuals awaiting an ostomy and those living with one
- Webinar: Intimacy and Cancer
- Left Vs. Right Sided Colorectal Tumors: A Clinical Presentation by Dr. Scott Berry
- Ask a Doctor : Q&A on Radiotherapy
- FDA clears new drug application for CAR-T cell therapy for the treatment of solid tumours
- Update on the role of low-dose aspirin in colorectal cancer prevention
- Interview: Jason Abramovitch
- Living with LARS: Naturopathy
- Living with LARS: Nutrition
- Cancer Screening in Canada: Interview with Dr. Mel Borins
- Interview: Jason from Man Up to Cancer
- Acupressure and Auricular Therapy for Symptom Management
- Underrepresentation in cancer clinical trials
- First-line nivolumab plus low-dose ipilimumab for MSI-high/MMR-deficient mCRC
- Highlights from the phase III EPOCH trial
- Impact of tumour vaccine on increasing anti-cancer response
- ESMO 2021 Congress: CRC highlights
- Antibiotic use and colon cancer: more evidence of link
- Clinical implications of the ongoing GALAXY trial
- Developing a better fecal immunochemical test (FIT) for colon cancer screening
- Colon cancer data reinforce need to reduce unnecessary antibiotic use
- Red meat consumption may promote DNA damage-associated mutations in patients with colorectal cancer
- Is it time for universal genetic testing in colorectal cancer?
- USPSTF final recommendation on CRC screening: 45 is the new 50
- Periodontal disease can be a potential risk indicator for colorectal cancer
- FDA Oks marketing of first AI device used to detect lesions during colonoscopy
- Foods that Fight Cancer: Recipe Videos
- OICR Translational Research Conference
- Addressing cancer disparities in Canada
- The role of maintenance strategies in metastatic colorectal cancer
- Liquid biopsy for colorectal cancer could guide therapy for tumours
- ASCO names molecular profiling of gastrointestinal cancer “Advance of the Year”
- The Importance of Self-care for Caregivers
- Rates of eligible people missing timely cancer screenings: A Canadian analysis
- Postsurgical disease recurrence in stage I to III colorectal cancer may be predicted by ctDNA
- Survey Results: Never Too Young
- Statins reduced risk of colorectal cancer in meta-analysis
- Hepatic Artery Infusion pumps in patients with colorectal cancer with liver metastases
- “Test all patients with cancer”: 1 in 8 have inherited mutations
- Rectal cancer management: do all patients need to undergo surgery?
- Palliative care for young adults is a growing reality in CRC
- OPTIMISTICC Research Program sheds light on importance of gut microbiome in colorectal cancer development and treatment
- Cancer Survivors Urgently Need Better Nutritional Support
- Intimacy and Colorectal Cancer
- Understanding early-onset colorectal cancer: why are cases on the rise?
- World Metastatic Colorectal Cancer Day
- Optimal sequencing strategies in metastatic colorectal cancer
- ESMO Virtual Congress 2020: Colorectal cancer highlights
- Welcoming Our Newest CCC Ambassador, Jesse Fishman!
- Do young diabetes patients need early CRC screening?
- Cancer Recurrence amid COVID-19: Robin’s Story
- Never Too Young Survey Launch
- Gut bacteria found to modulate response to cancer immunotherapy
- Your Seasonal Guide to Cancer-Fighting Foods
- Psychosocial support for patients with cancer during COVID-19
- COVID-19 NEWSLETTER
- CRC with peritoneal metastases: CRS-HIPEC refinements
- Four actionable targets for metastatic colorectal cancer
- Patient Group Pathway Model to Accessing Cancer Clinical Trials and RWE Conference
- Lynch Syndrome, Explained
- COVID-19 PATIENT SURVEY REPORT
- PUSH FOR YOUR TUSH VIRTUAL EVENT 2020
- Gastrointestinal Highlights from last month’s ASCO 2020 Meeting
- How is colorectal cancer care changing in the era of COVID-19?
- Meatless for CRC prevention
- Immunotherapy treatment proves to be superior to chemotherapy for a specific subset of patients with mCRC
- Push For Your Tush volunteers spread the word
- 2,700 VISITORS PASS THROUGH GIANT COLON TOUR AT THE SHERBROOKE HALF MARATHON
- Colorectal cancer screening in Ontario is changing to the FIT
- Remembering the “Father of Heredity Cancer” Dr. Henry Lynch
- Kicking cancer’s ass on the golf course
- Increasing rates of colon & rectal cancers in young people
- CCC attends Early Age Onset Colorectal Cancer Summit in New York City
- Publication: Clinically meaningful survival benefit in refractory mCRC
- Giant Colon visits University of Montreal Hospital Centre
- CCC’s PUSH FOR YOUR TUSH SPARKS PARTNERSHIP WITH THE TORONTO PROFESSIONAL FIRE FIGHTERS ASSOCIATION
- March is Colorectal Cancer Awareness Month
- Category: Story
- Shane’s story
- Lisa’s story
- Rada’s Story
- Gaston’s Story
- Hanna’s Story
- Eric’s Story
- Coping with the impact of cancer on your mental health: Lisa Martin’s story
- Gordon Levine’s Story
- Sam Megarry’s Story
- Patient Story: Jordan
- BLOOM WHERE YOU’RE PLANTED: LESSONS LEARNED FROM MY CANCER JOURNEY
- Becky Cassidy’s Story
- Claudia Pavao: early age onset colorectal cancer and Lynch syndrome survivor
- Lisa Blobstein’s story
- Connie Pickett: Living with LARs
- Patient Story: Stephanie Budgell
- Patient Story: Bryna Dilman
- Patient Story: Haydn
- Gurvinder Garcha, Cancer Survivor
- Anita’s Story: How Dress in Blue Day Began
- Caregiver Story: Bunnie Schwartz
- Patient Story: Pierre
- Patient Story: Meagan
- Patient Story: Stephen
- Patient Story: Don McQuaig
- Patient Story: Henry Klumak
- Aneta’s Story
- My Cancer Story: Annette Reilly
- A PASSION FOR CARE – by Robert Hamilton
- Gemma’s Story
- Kathy Torunski’s Story
- VANESSA’S STORY
- Paul Smeltzer
- Mary Devera
- A Wife’s Worst Fear Realized – Gilda’s Story
- The Dark, Long and Winding Road…Dominic Loccisano’s Story
Popups
Event
- Colorectal Cancer Awareness Month
- PUSH FOR YOUR TUSH 2023, 25th Anniversary
- PUSH FOR YOUR TUSH 2022 IS BACK IN 5 CITIES AND VIRTUALLY NATIONWIDE!
- Kick Ass Golf Tournament 2023: Join us!
- Kick Ass Golf Tournament 2022: Join us!
- Young Survivors Week
- Colorectal Cancer Community Conference
- Colorectal Cancer Community Conference 2021
- Overview: 4th Annual Patient Group Pathway Model to Accessing Cancer Clinical Trials & RWE Methodologies Conference
- Patient Group Pathway Model to Accessing Cancer Clinical Trials and RWE Conference
